Literature DB >> 18166184

Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness.

Panagiotis Bakas1, Angelos Liapis, Spiros Vlahopoulos, Maria Giner, Stella Logotheti, Georgios Creatsas, Aggeliki K Meligova, Michael N Alexis, Vassilis Zoumpourlis.   

Abstract

OBJECTIVE: To investigate the relative expression and the DNA-binding status of estrogen receptors alpha and beta in fibroids and normal myometrial tissue to explore the molecular basis of altered estrogen responsiveness of leiomyomas.
DESIGN: Biopsy samples from uterine fibroids and adjacent normal myometrial tissue at the follicular phase of the menstrual cycle.
SETTING: Aretaieio University Hospital and the National Hellenic Research Foundation, Athens, Greece. PATIENT(S): Thirty-five patients who underwent hysterectomy or myomectomy because of myoma symptoms. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Deoxyribonucleic acid-binding status of estrogen receptors alpha and beta. RESULT(S): The level of messenger RNA expression of estrogen receptor alpha and beta and the level of estrogen receptor as a whole are increased on average to a similar extent in leiomyomas compared with normal myometrium. Occasionally, however, estrogen receptor alpha is disproportionately increased in leiomyomas, and this appears to increase the amount of estrogen receptor alpha that binds to the estrogen-responsive element of estrogen target genes as homodimer rather than as heterodimer with estrogen receptor beta. CONCLUSION(S): The estrogen receptor alpha-to-estrogen receptor beta expression ratio rather than the individual expression levels determines the fraction of DNA-binding homodimers of estrogen receptor alpha and possibly the growth potential of myomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18166184     DOI: 10.1016/j.fertnstert.2007.09.019

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  14 in total

Review 1.  Estrogen receptors and human disease: an update.

Authors:  Katherine A Burns; Kenneth S Korach
Journal:  Arch Toxicol       Date:  2012-05-31       Impact factor: 5.153

2.  Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.

Authors:  Kristie Mozzachio; Alicia B Moore; Grace E Kissling; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2015-12-20       Impact factor: 1.902

3.  Hypertrophic cervical elongation: clinical and histological correlations.

Authors:  Okechukwu A Ibeanu; Ralph R Chesson; Dane Sandquist; Javier Perez; Kerri Santiago; Thomas E Nolan
Journal:  Int Urogynecol J       Date:  2010-03-24       Impact factor: 2.894

4.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

5.  Chromosomal Translocation t(5;12)(p13;q14) Leading to Fusion of High-mobility Group AT-hook 2 Gene With Intergenic Sequences From Chromosome Sub-Band 5p13.2 in Benign Myoid Neoplasms of the Breast: A Second Case.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Marius Lund-Iversen; Hanne Regine Hognestad; Ingvild Lobmaier; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

6.  Expanding upon the Human Myometrial Stem Cell Hypothesis and the Role of Race, Hormones, Age, and Parity in a Profibroid Environment.

Authors:  Lauren E Prusinski Fernung; Kimya Jones; Aymara Mas; Daniel Kleven; Jennifer L Waller; Ayman Al-Hendy
Journal:  Am J Pathol       Date:  2018-08-01       Impact factor: 4.307

7.  Circulating Sex Hormones and Risk of Uterine Fibroids: Study of Women's Health Across the Nation (SWAN).

Authors:  Jason Y Y Wong; Ellen B Gold; Wesley O Johnson; Jennifer S Lee
Journal:  J Clin Endocrinol Metab       Date:  2015-12-15       Impact factor: 5.958

8.  The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor.

Authors:  Benjamin Small; Charles E F Millard; Edwina P Kisanga; Andreanna Burman; Anika Anam; Clare Flannery; Ayman Al-Hendy; Shannon Whirledge
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

9.  Progression of mouse skin carcinogenesis is associated with increased ERα levels and is repressed by a dominant negative form of ERα.

Authors:  Stella Logotheti; Dimitra Papaevangeliou; Ioannis Michalopoulos; Maria Sideridou; Katerina Tsimaratou; Ioannis Christodoulou; Katerina Pyrillou; Vassilis Gorgoulis; Spiros Vlahopoulos; Vassilis Zoumpourlis
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

10.  Estrogen Regulates MAPK-Related Genes through Genomic and Nongenomic Interactions between IGF-I Receptor Tyrosine Kinase and Estrogen Receptor-Alpha Signaling Pathways in Human Uterine Leiomyoma Cells.

Authors:  Linda Yu; Alicia B Moore; Lysandra Castro; Xiaohua Gao; Hoang-Long C Huynh; Michelle Klippel; Norris D Flagler; Yi Lu; Grace E Kissling; Darlene Dixon
Journal:  J Signal Transduct       Date:  2012-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.